Guifeng Wang
- Hepatology top 5%
- Hepatitis C virus research 9
- Biochemistry top 10%
- Pharmacology top 10%
-
- Acupuncture Treatment Research Studies 3
- Infectious Diseases top 10%
- Viral gastroenteritis research and epidemiology 3
- HIV/AIDS drug development and treatment 3
-
- Hepatitis B Virus Studies 8
-
- Monoclonal and Polyclonal Antibodies Research 4
-
- Nerve injury and regeneration 3
-
- HER2/EGFR in Cancer Research 3
- Cited by
- HepatologyBiochemistryPharmacology
- Journals
- PLoS ONE (1 paper)International Journal of Molecular Sciences (2 papers)Antimicrobial Agents and Chemotherapy (1 paper)
- Partner nations
- ChinaJapanUnited States
In The Last Decade
Guifeng Wang
28 papers receiving 805 citations
Peers
Comparison fields: 5 of 101
- Hepatology 157
- Biochemistry 76
- Pharmacology 72
- Complementary and alternative medicine 56
- Infectious Diseases 125
Countries citing papers authored by Guifeng Wang
This map shows the geographic impact of Guifeng Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guifeng Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guifeng Wang more than expected).
Fields of papers citing papers by Guifeng Wang
This network shows the impact of papers produced by Guifeng Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guifeng Wang. The network helps show where Guifeng Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Guifeng Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2022 | 5 | |
| 3 | 2022 | 8 | |
| 4 | 2022 | 18 | |
| 5 | 2022 | 6 | |
| 6 | 2022 | 3 | |
| 7 | 2021 | 38 | |
| 8 | 2021 | 7 | |
| 9 | 2021 | 34 | |
| 10 | 2017 | 5 | |
| 11 | 2016 | 12 | |
| 12 | 2016 | 20 | |
| 13 | 2015 | 29 | |
| 14 | 2014 | 44 | |
| 15 | 2014 | 47 | |
| 16 | 2014 | 0 | |
| 17 | 2011 | 32 | |
| 18 | 2010 | 48 | |
| 19 | 2010 | 35 | |
| 20 | 2008 | 6 |
About Guifeng Wang
Guifeng Wang is a scholar working on Hepatology, Infectious Diseases and Complementary and alternative medicine, having authored 30 papers that have together received 830 indexed citations. Recurring topics across this work include Hepatitis C virus research (9 papers), Hepatitis B Virus Studies (8 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Viral gastroenteritis research and epidemiology (3 papers), Nerve injury and regeneration (3 papers), HER2/EGFR in Cancer Research (3 papers), HIV/AIDS drug development and treatment (3 papers) and Acupuncture Treatment Research Studies (3 papers). The work is most often cited by research in Hepatology (157 citations), Biochemistry (76 citations) and Pharmacology (72 citations). Guifeng Wang has collaborated with scholars based in China, Japan and United States. Frequent co-authors include Jianping Zuo, Wei Tang, Pei‐Lan He, Liping Shi, Fenghua Zhu, Pei‐Zhen Tao, Rujun Zhang, Yudan Ren, Qun‐Fang Liu and Zhuang Li. Their work appears in journals such as PLoS ONE, International Journal of Molecular Sciences and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.